Belarusian oncologists on way to completing scientific project on Elenagen vaccine

17 октября 2022
The Belarusian oncologists are on the way to completing the scientific project on the Elenagen vaccine. Five-year clinical trials of the drug have positive results. And although the experiment continues, the technology for manufacturing the drug is already being transferred to production. 

Elenagen is a vaccine designed to treat cancer patients with such diagnoses as ovarian cancer and triple-negative breast cancer. 

On the World Breast Cancer Day, the Alexandrov Republican Scientific-Practical Center reported a number of other research projects aimed at effective treatment of women with malignant neoplasms. 

The problem of oncomammology ranks first among other cancer diagnoses in women. Medical professionals continue to urge women to participate in screening programs and timely diagnosis.